InsidersTradesSigma
Follow the 澳华内镜 stock price and the full insider trade history of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 澳华内镜 has logged 5 insider filings. Market capitalisation: €3.4bn. The latest transaction was reported on 16 December 2025 (Sale). Among the most active insiders: 顾小舟. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
澳华内镜 es una empresa especializada en el desarrollo y la fabricación de instrumentos médicos, en particular endoscopios. Cotiza en la Bolsa de Shanghái.